Moreover, 5-year survival rates dropped to ~ 12% in bladder cancer patients with low expression of signature 1 genes (high-risk), which included KDM8 and PCDHA1 mutations. The gene discussed is PCDHA1; the disease is urinary bladder carcinoma.